Yuti Bi

发表

Integration of MyD88 inhibitor into mesoporous cerium oxide nanozymes-based targeted delivery platform for enhancing treatment of ulcerative colitis.

Xing Tang, Yu Zhang, Haibing He, 2023, Journal of controlled release : official journal of the Controlled Release Society.